Paul M Grandgenett

Author PubWeight™ 6.54^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	ADH-1 suppresses N-cadherin-dependent pancreatic cancer progression.	Int J Cancer	2008	1.08
2	Expression and function of the Trypanosoma brucei major surface protease (GP63) genes.	J Biol Chem	2003	1.06
3	Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras.	Clin Cancer Res	2011	1.00
4	Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer.	Cancer Immunol Immunother	2012	0.91
5	MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer.	PLoS One	2013	0.87
6	Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy.	Clin Cancer Res	2013	0.85
7	Expression of core 3 synthase in human pancreatic cancer cells suppresses tumor growth and metastasis.	Int J Cancer	2013	0.82
8	MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer.	Cancer Cell	2017	0.75